Professional Overview
Colin Taylor is an experienced Finance Manager with a strong background in financial planning and analysis (FP&A), accounting, and business strategy. He specializes in the healthcare and technology industries, leveraging his expertise to drive financial performance and strategic decision-making.
Experience Summary
Current Role
As Finance Manager at NeoGenomics Laboratories, Colin is responsible for overseeing the company's financial planning, budgeting, and analysis. He partners closely with cross-functional leaders to provide data-driven insights that support the organization's growth and operational efficiency. Under Colin's leadership, the finance team has implemented new forecasting models and streamlined reporting processes, leading to improved financial visibility and decision-making.
Career Progression
Prior to his current role, Colin held various finance leadership positions, including Head of FP&A / Director of FP&A at Natural Fiber Welding and Finance Manager (FP&A) at Ascom. In these roles, he played a pivotal role in driving strategic initiatives, optimizing financial processes, and supporting business transformation. Colin's diverse background also includes experience as a Corporate Controller and Finance Manager at BAE Systems, where he honed his expertise in accounting, reporting, and financial planning.
Academic Background
Colin holds a Bachelor of Science degree in Accounting from the University of South Florida. He is a Certified Public Accountant (CPA) and has completed additional training in leadership and strategic management.
Areas of Expertise
- Financial planning and analysis (FP&A)
- Budgeting and forecasting
- Financial reporting and business performance monitoring
- Strategic financial decision-making
- Cross-functional collaboration and stakeholder management
- Process improvement and operational optimization
Professional Impact
Throughout his career, Colin has demonstrated a track record of driving tangible business impact. At Natural Fiber Welding, he led the implementation of a new FP&A system, which resulted in a 25% reduction in reporting cycle time and improved data-driven decision-making. At Ascom, he spearheaded the integration of financial data across the organization, enhancing visibility and enabling more informed strategic planning.
Conclusion
With his extensive finance expertise, strategic mindset, and proven ability to collaborate with cross-functional teams, Colin is poised to continue making a significant impact in his role at NeoGenomics Laboratories. He is committed to leveraging his financial acumen to support the company's growth and profitability, ultimately contributing to its long-term success.
